Skip to content

Carl Zeiss Meditec's China slump rattles investors and BMW's supply chain

A sharp decline in China sales sends shockwaves through Zeiss's business—and BMW's production lines. Will the optics leader recover before disruptions spread?

The image shows the BMW headquarters in Frankfurt, Germany. It is a large building with glass walls...
The image shows the BMW headquarters in Frankfurt, Germany. It is a large building with glass walls and doors, and text on the building. There are people walking on the road in front of the building, and a tree on the left side of the image.

Carl Zeiss Meditec's China slump rattles investors and BMW's supply chain

Carl Zeiss Meditec, a key supplier of precision optics, is facing growing difficulties in China. The company's struggles have raised concerns among investors and major customers, including BMW. Recent financial setbacks and operational challenges are now putting pressure on its market position.

The German firm has seen its revenue share from China fluctuate sharply in recent years. After rising from 14% in 2022/23 to 17% in 2023/24, it dropped to just 12% in 2024/25. Weak demand, geopolitical tensions, and increased competition from local manufacturers have all played a role in this decline. Currency headwinds have added to the strain, squeezing profit margins further.

Institutional investors have responded by reducing their stakes, pushing the company's share price to a 52-week low. The downturn also led to its demotion from Germany's MDAX to the smaller SDAX index. Market watchers are now awaiting details of stabilisation plans, expected to be announced at the upcoming annual general meeting. BMW, which depends on Zeiss optics for driver-assistance systems and head-up displays, could face production delays or higher costs if the supplier's troubles continue. Analysts are questioning whether the automaker will seek alternative suppliers to reduce its exposure to these risks. So far, BMW's stock has remained steady, but concerns linger over potential supply chain disruptions.

Carl Zeiss Meditec's financial and operational challenges are creating ripple effects across its supply chain. The company's next moves will be closely scrutinised, particularly by major clients like BMW. Any prolonged instability could lead to broader production and cost issues in the automotive sector.

Read also:

Latest